Brake et al (2003) focused on MCM7 in cervical cancer and Helfenstein et al (2004) on MCM6 in chondrosarcoma using the monoclonal antibody Ki-MCM6, also employed in our study. Here, PSME3 is linked to chondrosarcoma.